
Gene Sequencing Technology R&D Provider
Following the release of QNome-3841, China’s first commercially available nanopore gene sequencer, in December 2021, QitanTech, a rising star in China’s nanopore gene sequencing sector, recently announced that its “2022 QitanTech New Product Launch and Online Academic Symposium” will be held online on June 28.

Scan the QR code to enter the live stream
Themed “Harnessing Qitan’s Strength to Discuss Pathogens Together,” this new product launch event will unveil the QNome-3841hex, a novel nanopore gene sequencer independently developed by QitanTech, and invite renowned industry experts and professors to engage in discussions, sparking new thinking on the application of domestically produced nanopore gene sequencers in microbiological research.
It is reported that QitanTech is set to launch a new addition to its QNome family—the QNome-3841hex nanopore gene sequencer. Positioned as a desktop gene sequencer with flexible throughput, it overcomes the limitations of conventional laboratory environments, enabling rapid on-site pathogen detection and timely access to relevant information, thereby facilitating more swift and accurate detection of pathogenic microorganisms.
QitanTech previously stated that 2022 marked the first year of its commercialization, with its first mass-produced model, the QNome-3841, launched on the market and progressively delivered for use, demonstrating a strong start. Just half a year later, QitanTech officially announced another new release. What new surprises will QitanTech bring to the industry this time? Can it secure a place in the rapidly evolving gene sequencing market?
June 28, 10:00 AM—stay tuned!
